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Abstract
Background: Recent studies revealed elevated serum ferritin levels predict new-onset type 2 diabetes. Further studies 
proved ferritin to be an important and independent predictor of the development of diabetes. The link between hyperglycemia, 
enhanced free radical activity (oxidative stress) and serum iron and its stores (serum ferritin levels) levels is not clear. 
Objectives: The present study is an attempt to understand the relationship between serum ferritin levels and oxidative 
stress (measured by malondialdehyde).
Materials and Methods: The study comprised of 30 apparently healthy controls and 30 type 2 diabetic patients 
who attended the outpatient and inpatient departments of Medical College, Kolkata. Levels of fasting blood glucose, 
postprandial blood glucose, serum iron, serum ferritin, glycosylated hemoglobin (HbA1c) and malondialdehyde (MDA), 
serum urea and creatinine were estimated. The statistical software SPSS 11.0 and Systat 8.0 were used for the analysis 
of the data and Microsoft Word and Excel have been used to generate tables and graphs.
Results: Serum iron (82.16 ± 13.24 µg/dl), serum ferritin (224.53 ± 96.06 µg/L), HbA1c (8.62 ± 1.79%), MDA 
(2.66 ± 0.76 nmol/ml) levels were significantly higher in type 2 diabetics compared with apparently healthy controls. 
Elevations in serum iron, ferritin and HbA1c are accompanied by a parallel increase in blood glucose. Based on groups 
of glycemic control, i.e. HbA1c levels >8%, serum ferritin levels were highest, 258.63 ± 22.67 µg/dl. There is an inverse 
correlation of serum ferritin levels to MDA levels in the diabetic cases of longer duration of more than 10 years.
Conclusion: Serum ferritin level in the present study is found to be higher in the newly diagnosed cases and lower 
in those patients suffering from diabetes for more than 10 years. This study probably suggests that serum ferritin can 
represent either as a pro-oxidant or as an antioxidant in a time-dependent manner.
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Introduction
Elevated iron stores may increase the risk of developing 
diabetes.[1] Emerging scientific evidence has revealed 
unsuspecting influences between iron metabolism and 
NIDDM. The relationship is bi-directional, iron affects 
glucose metabolism, and glucose metabolism impinges 
on several iron metabolic pathways. It is increasingly 
recognized that iron influences glucose metabolism, 
even in the absence of significant iron overload. Serum 
ferritin is known as an index for body iron stores and 
also as an inflammatory marker. Increased serum ferritin 
concentration is associated with an increased risk of 
diabetes mellitus. Serum ferritin levels predict new-onset 
type 2 diabetes.[2] Elevated iron stores could enhance 
oxidation of lipids, especially of free fatty acids; through 
accelerated production of free radicals. The complex 
process of advanced glycation end product formation 
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produces reactive oxygen species (ROS) by metal 
catalyzed reactions. Advanced glycation end products 
themselves bind transition metals, potentiating their 
toxic effects, including insulin resistance. ROS interfere 
with insulin signaling at various levels, impairing insulin 
uptake through a direct effect or insulin receptor functions 
and inhibiting the translocation by GLUT4 in the plasma 
membrane. Iron through Fenton’s reaction participates 
in the formation of highly toxic free radicals such as 
hydroxide and the superoxide anion that are capable 
of inducing lipid peroxidation. Hydroperoxides react 
with transition metals to form stable aldehydes, such as 
malondialdehyde (MDA). ROS can stimulate vascular 
smooth muscle cell growth and protooncogene expression.
In patients with type 2 diabetes mellitus, higher levels of 
MDA, a marker of lipid peroxidation is found. Oxidative 
stress induces both insulin resistance by decreasing 
internalization of insulin and increased ferritin synthesis.[3] 
Both at transcriptional and posttranscriptional levels, 
synthesis of apoferritin are induced by the presence of 
free iron. The heavy chain in the apoferritin molecule 
exerts ferroxidase activity, catalyzing the oxidation of 
Fe2+ to Fe3+, which prevents iron-induced cyclic redox 
reaction that would spread and amplify the oxidative 
damage. The ferroxidase activity in the heavy chain is 
down regulated when concentration of antioxidants 
are low, Therefore, there is a rapid release of iron from 
ferritin as well as there is a decrease in the incorporation 
of iron into ferritin. The present study is an attempt to 
understand the relation between serum iron and ferritin 
to oxidative stress (MDA).
Materials and Methods
The study was conducted after obtaining usual permission 
from ethical committee, and consent from subjects and 
controls were taken before commencing the study. The 
study comprised of 30 apparently healthy controls and 
30 type 2 diabetic patients, who attended the outpatient 
and inpatient departments of Medical College, Kolkata. 
The inclusion criteria were male subjects in the age group 
of 40–60 years with type 2 diabetes mellitus without 
complications. Exclusion criteria included anemia, any 
other disease or drugs, anemia therapy that could affect 
ferritin levels. Patients having renal disease were excluded 
from the study determining the serum levels of urea and 
creatinine. Patients suffering from hemochromatosis were 
excluded from the study. History and physical data was 
obtained from both cases and controls. Determination 
of serum malondialdehyde (TBARS method),[4] serum 
iron (colorimetric method),[5] serum ferritin (Enzyme 
Immunoassay)[6] along with estimations of both fasting 
blood glucose (FBG) and postprandial blood glucose 
(PPBG) by (glucose oxidase method)[7] and glycosylated 
hemoglobin (immunoinhibition method),[8] serum 
creatinine (Jaffe’s method),[9] serum urea (UV method)[10] 
were carried out.
Statistical analysis
Chi-Square test has been used to find the homogeneity of 
sex distribution between apparently healthy controls and 
diabetic cases. Student’s t test (independent two tailed) 
has been used to find the significance of serum ferritin and 
other biochemical parameters between these two groups. 
The effect sizes due to Hedges (Bias Corrected) have been 
computed to find the effect of diabetes on biochemical 
parameters over the control group. Pearson’s correlation 
coefficient (r) has been calculated. The statistical software 
SPSS 11.0 and Systat 8.0 were used for the analysis of the 
data and Microsoft Word and Excel have been used to 
generate the tables and graphs.
Results
There was a significant elevation in the cases in the levels of 
FBG (138.47 ± 30.51 mg/dl), PPBG (232.37 ± 51.13 mg/dl) 
and is of statistical significance (P < 0.001). Mean values of 
HbA1c was found to be (8.62 ± 1.79%) in cases compared 
with mean values of HbA1c i.e. (5.54 ± 0.22%) with 
controls and is statistically significant (P < 0.001). Serum 
iron content (82.16 ± 13.24 µg/dl) in the cases is found 
to be higher than controls (77.81 ± 13.05 µg/dl) but not 
statistically significant (P < 0.204). Mean values of serum 
ferritin is higher in cases (224.53 ± 96.06 µg/l) compared 
with controls (78.09 ± 14.60 µg/L) and is statistically highly 
significant (P < 0.001). Mean values of MDA were higher 
in cases (2.66 ± 0.76 nmol/ml) compared with controls 
(1.59 ± 0.36 nmol/ml) and is of statistical significance 
(P < 0.001). Serum levels of ferritin, iron and MDA and 
HbA1c in cases and controls are depicted in Table 1.
When cases were grouped based on glycemic control (HbA1c 
values) i.e. good control (6-7% HbA1c), moderate control 
(>7-8% HbA1c) and poor control (>8% HbA1c), the serum 
ferritin level was highest 258.63 ± 22.67 µg/l in groups 
with poor glycemic control. The same was much lower 
183.43 ± 75.36 µg/l, in group of cases with good glycemic 
control. Percentage of diabetic cases and serum ferritin levels 
based on groups of glycemic control are depicted in Table 2.
Serum ferritin and MDA levels are found to be higher in 
diabetic cases with longer duration of diabetes and are 
168.38 ± 43.25 µg/l and 3.58 ± 0.53 nmol/ml, respectively. 
Percentage of diabetic cases, serum ferritin levels and MDA 
levels based on duration of diabetes are depicted in Table 3.
Pearson’s correlation co-efficient (r) has been calculated and 
the (r value) with P value are depicted in Table 4.
Correlation of serum ferritin to MDA in cases and controls 
is projected in scattered graphs in Figures 1 and 2.
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Discussion
Significant hyperglycemia-both FBG and PPBG–was 
observed in cases. Glycosylated hemoglobin (HbA1c) used 
in long-term monitoring of diabetes mellitus is higher 
in cases (P < 0.001). Many studies have reported that 
post-translational modification of ferritin with glucose 
causes change of its immunochemical properties, and 
changes in iron metabolism affects the level of HbA1c in 
diabetics.[11] Among the cases with poor glycemic control 
(>8% HbA1c), serum iron and serum ferritin levels were 
higher and is in agreement with several other studies. Serum 
ferritin level is elevated in type 2 diabetes (P < 0.001). 
A recent finding with 1013 Finnish men is that there is a 
positive association between ferritin and type 2 diabetes.[12] 
Another study has also shown a strong association between 
serum ferritin and incidence of diabetes.[13] Elevated ferritin 
levels are indicated to be due to elevated body iron stores or 
ferritin is an acute-phase reactant and elevated ferritin may 
reflect inflammation or delayed clearance of glycosylated 
ferritin. It is also suggested that ferritin level is increased 
due to lack of glycemic control. One study suggested that 
treating diabetic patients with deferoxamine lowered ferritin 
concentrations and improved the management of diabetes, 
but these findings were not confirmed in subsequent studies. 
Serum ferritin level in the present study is found to be higher 
in the newly diagnosed cases and low in those patients 
suffering from diabetes for more than 10 years. The results 
are in agreement with the previous studies. Elevated serum 
ferritin could be a marker of insulin resistance and this may 
account for elevated FBG and PPBG in cases. Obviously, 
further research is needed on the associations of serum 
ferritin concentration with insulin resistance and other 
components of the insulin resistance syndrome.
MDA is one of the lipid peroxidation products frequently 
used to assess the state of oxidative stress in diabetics. In the 
Table 1: Serum levels of ferritin, iron and MDA and 
HbA
1c
 in cases and controls
Biochemical Parameter Control Cases P value
FBG (mg/dl) 82.23±10.04 138.47±30.51 <0.001
PPBG (mg/dl) 128.53±8.49 232.37±51.13 <0.001
Serum MDA (nmol/ml) 1.59±0.36 2.66±0.76 <0.001
HbA
1c
 (%) 5.54±0.22 8.62±1.79 <0.001
Serum Ferritin (µg/l) 78.09±14.60 224.53±96.06 <0.001
Serum Iron (µg/dl) 77.81±13.05 82.16±13.24 <0.2.4
Table 2: Percentage of diabetic cases and serum 
ferritin levels based on groups of glycemic control
Classification of cases 
based on HbA
1C
% of cases Serum ferritin (µg/l)












Table 3: Percentage of cases, serum ferritin and MDA 
levels based on duration of diabetes
Duration of 
type 2 diabetes





≤5 years 46.67 281.38±105.63 2.08±0.51
6-10 years 33.33 178.63±55.17 2.92±0.43
>10 years 20.00 168.38±43.25 3.58±0.53
Significance P<0.006 P<0.001
Table 4: Correlation of serum ferritin with other 
parameters in controls and cases
Correlation of serum 
ferritin levels to other 
parameters
Control (r value) Case (r value)






















Figure 2: Correlation of serum ferritin to MDA levels in cases
Figure 1: Correlation of serum ferritin to MDA levels in controls
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present study, lipid peroxidation is significantly increased 
in type 2 diabetics compared with controls (P < 0.001). 
Although increased levels of MDA has been reported in 
both type 1 and type 2 diabetes in many studies, some 
studies have failed to detect any significant elevation in 
lipid peroxidation.[14] We have found that elevated MDA 
level correlates with poor glycemic control and its finding is 
the same with several other studies. Jain et al. reported that 
poor glycemic status could produce permanent chemical 
alterations in proteins and increase lipid peroxidation in 
experimental models of hyperglycemia. Hyperglycemia 
itself is suggested to stimulate platelet aggregation and 
auto-oxidation of glucose leading to free radical production 
in diabetics. The source of free radicals in diabetes is not well 
understood but glycation of proteins can lead to oxidative 
damage. Mean serum ferritin levels are highest in individuals 
with diabetes of shorter duration and are significantly 
different from levels of serum ferritin in individuals with 
previously diagnosed diabetes. Because serum ferritin levels 
reflect the sum of body iron stores and the production of 
acute-phase reactants, changes in either can alter ferritin 
levels. Thus, the lower mean ferritin levels in individuals 
with previously diagnosed diabetes may be due to changes 
in body iron stores or may be due to changes in factors 
that affect the production of acute-phase reactants.[15] It 
is said that ferritin and its formation can protect against 
iron toxicity, thus causing decrease in oxidative stress. But 
as the duration of diabetes increases there is an increase 
in oxidative stress and other complications. This leads 
to the lowering of ferritin levels and release of free iron 
contributing to further increase in oxidative stress.[16] This 
clearly explains our observation of inverse relation between 
the ferritin level and the MDA level in the cases of longer 
duration of diabetes.
This study has several limitations. Firstly, it is a cross-sectional 
study comprising a small group; therefore, the directionality 
of associations cannot be clearly established. Secondly, 
although ferritin is considered a good measure of body iron 
stores, it is not a “gold standard”. Thirdly, ferritin is also an 
acute phase reactant and may be artificially elevated in the 
presence of inflammation. Similarly, residual confounding 
by unmeasured factors that may be related both to the 
prevalence of type 2 diabetes and to ferritin levels cannot be 
ruled out. This study seems to suggest that elevated ferritin 
can act as a pro-oxidant at the early onset of type 2 diabetes. 
So large-scale clinical trials to establish a relation between 
elevated serum ferritin levels and type 2 diabetes is worth 
undertaking. Further, this study suggests that this putative 
activity of ferritin may constitute a missing link in the 
regulatory loop between iron and reactive oxygen species.
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